导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 2.24% | 1701/4773 |
| 近一周 | -3.07% | 3619/5462 |
| 近一月 | -9.74% | 4842/5421 |
| 近一季 | -18.02% | 4644/5209 |
| 近半年 | -0.65% | 1350/4920 |
| 近一年 | 6.65% | 1428/4366 |
| 近两年 | 109.05% | 491/2954 |
| 近三年 | 66.55% | 356/2253 |
| 成立以来 | 78.24% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-0.84% 1987/4961 |
34.89% 942/5312 |
- - |
- - |
| 2025 | 48.28% 533/4813 |
-1.64% 2725/3635 |
3.23% 1095/4076 |
47.49% 459/4524 |
-0.98% 2761/4813 |
| 2024 | 15.19% 955/3463 |
-3.58% 1526/2808 |
-5.93% 1820/3014 |
27.59% 216/3129 |
-0.47% 1432/3463 |
| 2023 | -17.49% 1739/2656 |
2.01% 1465/2280 |
-6.76% 1701/2385 |
-8.99% 1763/2515 |
-4.67% 1138/2655 |
| 2022 | -27.07% 1454/2207 |
-18.48% 1344/1919 |
5.42% 907/2016 |
-17.12% 1556/2113 |
2.39% 953/2208 |
| 2021 | 13.41% 357/1822 |
-5.94% 966/1255 |
25.18% 94/1330 |
-5.84% 869/1466 |
2.29% 628/1822 |
| 2020 | - - |
- - |
- - |
6.21% 865/1164 |
14.52% 270/1184 |
| 2019 | - - |
- - |
- - |
- - |
- - |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 万家中证港股通创新药ETF | 1.5896 | 28.31% |
| 港股医疗ETF | 1.4282 | 28.15% |
| 天弘恒生沪深港创新药精选50ETF | 0.8437 | 27.35% |
| 华富中证港股通创新药指数型发起式A | 1.1464 | 27.24% |
| 嘉实中证港股通创新药指数发起式C | 0.8441 | 26.80% |
| 中欧中证港股通创新药指数发起A | 1.5868 | 26.75% |
| 中欧中证港股通创新药指数发起C | 1.4370 | 26.67% |
| 永赢中证港股通医疗主题ETF发起联接A | 0.8762 | 26.58% |
| 华夏中证港股通医疗主题ETF发起式联接A | 0.8585 | 26.45% |
| 华夏中证港股通医疗主题ETF发起式联接C | 0.8568 | 26.39% |
| 平安创业板ETF联接C VS. 长安沪深300非周期A(740101) |